Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Totally laparoscopic right hepatectomy for living donor liver transplantation. Analysis of a preliminary experience on 5 consecutive cases.

Rotellar F, Pardo F, Benito A, Zozaya G, Martí-Cruchaga P, Hidalgo F, Lopez L, Iñarrairaegui M, Sangro B, Herrero I.

Transplantation. 2016 Oct 17. [Epub ahead of print]

PMID:
27755505
2.

Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients.

Pascual J, Royuela A, Fernández AM, Herrero I, Delgado JF, Solé A, Guirado L, Serrano T, de la Torre-Cisneros J, Moreno A, Cordero E, Gallego R, Lumbreras C, Aguado JM; Spanish Society of Transplantation Virological and Immune Response Investigation Study Group..

Transpl Infect Dis. 2016 Dec;18(6):819-831. doi: 10.1111/tid.12601. Review.

PMID:
27600985
3.

Controlling Diabetes After Liver Transplantation: Room for Improvement.

Alvarez-Sotomayor D, Satorres C, Rodríguez-Medina B, Herrero I, de la Mata M, Serrano T, Rodríguez-Perálvarez M, DʼAvola D, Lorente S, Rubín A, Berenguer M.

Transplantation. 2016 Oct;100(10):e66-e73.

PMID:
27653229
4.

Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis.

Lara B, Blanco I, Martínez MT, Rodríguez E, Bustamante A, Casas F, Cadenas S, Hernández JM, Lázaro L, Torres M, Curi S, Esquinas C, Dasí F, Escribano A, Herrero I, Martínez-Delgado B, Michel FJ, Rodríguez-Frías F, Miravitlles M.

Arch Bronconeumol. 2017 Jan;53(1):13-18. doi: 10.1016/j.arbres.2016.05.003. English, Spanish.

5.

First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.

Martínez-Calle N, Alfonso A, Rifón J, Herrero I, Errasti P, Rábago G, Merino J, Panizo Á, Pardo J, Prósper F, García-Muñoz R, Lecumberri R, Panizo C.

Eur J Haematol. 2017 Jan;98(1):38-43. doi: 10.1111/ejh.12782.

PMID:
27232286
6.

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Torre-Cisneros J, Aguado JM, Caston JJ, Almenar L, Alonso A, Cantisán S, Carratalá J, Cervera C, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Frauca E, Gavaldá J, Hernández D, Herrero I, Len O, Lopez-Medrano F, Manito N, Marcos MA, Martín-Dávila P, Monforte V, Montejo M, Moreno A, Muñoz P, Navarro D, Pérez-Romero P, Rodriguez-Bernot A, Rumbao J, San Juan R, Vaquero JM, Vidal E; Spanish Society of Transplantation (SET).; Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC).; Spanish Network for Research in Infectious Diseases (REIPI)..

Transplant Rev (Orlando). 2016 Jul;30(3):119-43. doi: 10.1016/j.trre.2016.04.001. Review.

PMID:
27132815
7.

Factors related to increased resting energy expenditure in men with liver cirrhosis.

Prieto-Frías C, Conchillo M, Payeras M, Iñarrairaegui M, Davola D, Frühbeck G, Salvador J, Rodríguez M, Richter JÁ, Mugueta C, Gil MJ, Herrero I, Prieto J, Sangro B, Quiroga J.

Eur J Gastroenterol Hepatol. 2016 Feb;28(2):139-45. doi: 10.1097/MEG.0000000000000516.

PMID:
26560751
8.

Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.

Caston JJ, Castells L, Varo E, Gomez MA, de la Mata M, Campos-Varela I, Lumbreras C, Gonzalez-Dieguez L, Fabregat J, Herrero I, Salcedo M, Sanchez-Antolín G, Torre-Cisneros J.

Transplantation. 2016 Mar;100(3):593-9. doi: 10.1097/TP.0000000000000912.

PMID:
26371595
9.

In vivo horizontal dissemination of the blaKPC-2 gene carried on diverse genetic platforms among clinical isolates of Enterobacteriaceae.

Anchordoqui MS, De Belder D, Lucero C, Rapoport M, Faccone D, Rodriguez A, Di Martino A, Martino F, Herrero I, Pasteran F, Corso A, Gomez SA.

J Glob Antimicrob Resist. 2015 Sep;3(3):210-213. doi: 10.1016/j.jgar.2015.05.001.

PMID:
27873711
10.

Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.

Bilbao I, Salcedo M, Gómez MA, Jimenez C, Castroagudín J, Fabregat J, Almohalla C, Herrero I, Cuervas-Mons V, Otero A, Rubín A, Miras M, Rodrigo J, Serrano T, Crespo G, De la Mata M, Bustamante J, Gonzalez-Dieguez ML, Moreno A, Narvaez I, Guilera M; EVEROLIVER study group..

Liver Transpl. 2015 Aug;21(8):1056-65. doi: 10.1002/lt.24172.

11.

Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety.

Rotellar F, Pardo F, Benito A, Martí-Cruchaga P, Zozaya G, Lopez L, Hidalgo F, Sangro B, Herrero I.

Am J Transplant. 2013 Dec;13(12):3269-73. doi: 10.1111/ajt.12471.

12.

[Orthotopic liver transplantation in polycystic liver disease].

Arredondo J, Rotellar F, Herrero I, Pedano N, Martí P, Zozaya G, Bellver M, Pardo F.

Cir Esp. 2013 Dec;91(10):659-63. doi: 10.1016/j.ciresp.2012.11.010. Spanish.

13.

Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.

Reboredo M, Chang HC, Barbero R, Rodríguez-Ortigosa CM, Pérez-Vizcaíno F, Morán A, García M, Banales JM, Carreño N, Alegre F, Herrero I, Quiroga J, Prieto J, Sangro B.

PLoS One. 2013;8(1):e52683. doi: 10.1371/journal.pone.0052683.

14.

Case-based reasoning emulation of persons for wheelchair navigation.

Peula JM, Urdiales C, Herrero I, Fernandez-Carmona M, Sandoval F.

Artif Intell Med. 2012 Oct;56(2):109-21. doi: 10.1016/j.artmed.2012.08.007.

PMID:
23068883
15.

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation.

Gomez-Martin C, Bustamante J, Castroagudin JF, Salcedo M, Garralda E, Testillano M, Herrero I, Matilla A, Sangro B.

Liver Transpl. 2012 Jan;18(1):45-52. doi: 10.1002/lt.22434.

16.

Differential in vitro and in vivo effect of barley cysteine and serine protease inhibitors on phytopathogenic microorganisms.

Carrillo L, Herrero I, Cambra I, Sánchez-Monge R, Diaz I, Martinez M.

Plant Physiol Biochem. 2011 Oct;49(10):1191-200. doi: 10.1016/j.plaphy.2011.03.012.

PMID:
21482127
17.

The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients.

Grau T, Bonet A, Miñambres E, Piñeiro L, Irles JA, Robles A, Acosta J, Herrero I, Palacios V, Lopez J, Blesa A, Martínez P; Metabolism, Nutrition Working Group, SEMICYUC, Spain..

Crit Care Med. 2011 Jun;39(6):1263-8. doi: 10.1097/CCM.0b013e31820eb774.

PMID:
21336131
18.

Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells.

Fernandez-Ruiz V, Kawa M, Berasain C, Iñiguez M, Schmitz V, Martinez-Ansó E, Iñarrairaegui M, Herrero I, Sangro B, D'Avola D, Quiroga J, Qian C, Prieto J.

J Hepatol. 2011 Oct;55(4):828-37. doi: 10.1016/j.jhep.2011.01.036.

PMID:
21334399
19.

[Truancy in the wave of the epidemic in 2009-2010 influenza season schools of the city of Ceuta, Spain].

Barrientos MD, Toledo A, Rivas AI, Medina M, Padilla I, Herrero I.

Rev Esp Salud Publica. 2010 Sep-Oct;84(5):679-85. Spanish.

20.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, Echeverria I, Sarobe P, Herrero I, Sangro B, Prieto J, Lasarte JJ.

J Hepatol. 2011 Mar;54(3):422-31. doi: 10.1016/j.jhep.2010.07.014.

PMID:
21129807
Items per page

Supplemental Content

Loading ...
Support Center